obesity drug news today glp-1 september 22 2025 Nutritional priorities to support therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Medicine Association, and The Obesity Society GLP-1 Weight-Loss Drug Demonstration Begins
Description
D., Hansen, T., & Bain, S
Lorza-Gil et al
Inflammation in obesity, diabetes, and related disorders
Just as GLP-1 therapies reshaped metabolic medicine, new hair-loss breakthroughs may reshape the future of scalp health and follicle regeneration
Dose : The starting dose of Mounjaro is 2.5 mg delivered subcutaneously once weekly and titrates up to a maximum of 15 mg weekly
Statistical analyses Continuous variables are presented as means and standard deviations, and categorical variables are presented as frequencies and percentages
